Clearpoint Neuro Inc (CLPT)

Currency in USD
8.84
-0.97(-9.85%)
Closed·
8.94+0.11(+1.24%)
·
Unusual trading volume
Earnings results expected tomorrow
Trading near 52-week Low
CLPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.839.55
52 wk Range
8.8330.10
Key Statistics
Prev. Close
9.8
Open
9.5
Day's Range
8.83-9.55
52 wk Range
8.83-30.1
Volume
1.9M
Average Volume (3m)
761.68K
1-Year Change
-34.7601%
Book Value / Share
0.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLPT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.00
Upside
+228.05%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Clearpoint Neuro Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Clearpoint Neuro Company Profile

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Clearpoint Neuro Inc Earnings Call Summary for Q3/2025

  • ClearPoint Neuro (CLPT) missed Q3 2025 forecasts with $8.9M revenue (9.59% below expectations) and -$0.21 EPS, triggering a 6.89% stock drop in after-hours trading.
  • Despite overall misses, the company reported 9% YoY revenue growth, with Neurosurgery Navigation and Therapy segment up 20% and improved gross margin of 63% (from 60% in Q3 2024).
  • The company maintained its 2025 revenue forecast of $36-38M and projected 2026 pro forma revenue between $54-60M despite current challenges.
  • CEO Joe Burnett characterized the company as 'effectively pre-revenue in this phase,' emphasizing a strategic vision targeting $500M in annual revenue.
  • Strategic initiatives include expanding the CRO facility and integrating operations with IRRAS, though analysts noted potential integration challenges in a competitive neurosurgical navigation market.
Last Updated: 14/11/2025, 13:24
Read Full Transcript

Compare CLPT to Peers and Sector

Metrics to compare
CLPT
Peers
Sector
Relationship
P/E Ratio
−12.6x−3.3x−0.5x
PEG Ratio
0.82−0.170.00
Price/Book
18.4x4.7x2.6x
Price / LTM Sales
8.5x3.3x3.2x
Upside (Analyst Target)
195.9%41.0%47.3%
Fair Value Upside
Unlock9.5%6.7%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 29.00
(+228.05% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Buy28.00+216.74%20.00Maintain25/04/2025
Stifel
Buy25.00+182.81%19.00Maintain01/04/2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-0.21 / -0.18
Revenue / Forecast
8.86M / 9.80M
EPS Revisions
Last 90 days

People Also Watch

36.32
LPG
-3.51%
8.600
DCTH
-3.70%
10.205
HLIT
-6.72%
8.480
TTI
-4.93%
13.83
NPCE
-2.26%

FAQ

What Is the Clearpoint Neuro (CLPT) Share Price Today?

The Clearpoint Neuro stock price today is 8.84 USD.

What Stock Exchange Does Clearpoint Neuro (CLPT) Trade On?

Clearpoint Neuro is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Clearpoint Neuro?

The stock symbol (also called a 'ticker') for Clearpoint Neuro is "CLPT."

What Is the Current Clearpoint Neuro Market Cap?

As of today, Clearpoint Neuro market cap is 264.16M USD.

What Is Clearpoint Neuro's (CLPT) Earnings Per Share (TTM)?

The Clearpoint Neuro EPS is currently -0.83 (Trailing Twelve Months).

When Is the Next Clearpoint Neuro Earnings Date?

Clearpoint Neuro's next earnings report will be released on 04/03/2026.

Is CLPT a Buy or Sell From a Technical Analyst Perspective?

Based on today's Clearpoint Neuro moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Clearpoint Neuro Stock Split?

Clearpoint Neuro has split 1 times. (See the CLPT stock split history page for full effective split date and price information.)

How Many Employees Does Clearpoint Neuro Have?

Clearpoint Neuro has 115 employees.

What is the current trading status of Clearpoint Neuro (CLPT)?

As of 03/03/2026, Clearpoint Neuro (CLPT) is trading at a price of 8.84 USD, with a previous close of 9.80 USD. The stock has fluctuated within a day range of 8.83 USD to 9.55 USD, while its 52-week range spans from 8.83 USD to 30.10 USD.

What Is Clearpoint Neuro (CLPT) Price Target According to Analysts?

The average 12-month price target for Clearpoint Neuro is 29.00 USD, with a high estimate of 30 USD and a low estimate of 28 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +228.05% Upside potential.

What Is the CLPT Premarket Price?

CLPT's last pre-market stock price is 9.50 USD. The pre-market share volume is 22,360.00, and the stock has decreased by -0.30, or -3.06%.

What Is the CLPT After Hours Price?

CLPT's last after hours stock price is 8.94 USD, the stock has decreased by 0.11, or 1.24%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.